Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial) Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial)

Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial‪)‬

Clinical Chemistry 2003, August, 49, 8

    • 2,99 €
    • 2,99 €

Descrizione dell’editore

Measurement of glycohemoglobin (GHb) is an integral component of the management of patients with diabetes mellitus (1, 2). Glycation is the nonenzymatic addition of a sugar residue to amino groups of proteins. Numerous proteins in the body are glycated, but GHb in blood is the analyte most widely used clinically to monitor glycemic control. The concentration of GHb is directly proportional to the mean concentration of glucose in the blood and the lifespan of erythrocytes (mean, 120 days). Thus, the GHb concentration represents an integrated value for glucose over the preceding 2-3 months. GHb provides an index of glycemic control that is free of the wide diurnal glucose fluctuations and is unaffected by recent exercise or food ingestion. Two large, prospective, randomized clinical trials demonstrated a strong relationship between hyperglycemia and the development of microvascular complications of diabetes. In the Diabetes Control and Complications Trial (DCCT) and the United Kingdom Prospective Diabetes Study (UKPDS), which studied patients with type 1 and type 2 diabetes, respectively (3, 4), glycemic control was assessed by GHb. Both studies established a direct relationship between the GHb concentration and the risk of complications. These findings led the American Diabetes Association to recommend that a primary treatment goal in adults with diabetes should be near-normal glycemia with hemoglobin [A.sub.1c] (Hb[A.sub.1c]) 7% when measured by the method used for the DCCT (2). The recommendation that Hb[A.sub.1c] be measured at least every 6 months in patients with type 1 or type 2 diabetes (2) has had a dramatic impact on the use of this test. The number of laboratories participating in the GHb surveys offered by the College of American Pathologists increased from 707 in 1990 to 2008 in 2003. Clinical laboratories in the US currently perform 2 million GHb measurements each month (estimated from an unpublished survey by the College of American Pathologists).

GENERE
Scienza e natura
PUBBLICATO
2003
1 agosto
LINGUA
EN
Inglese
PAGINE
10
EDITORE
American Association for Clinical Chemistry, Inc.
DIMENSIONE
170,3
KB

Altri libri di Clinical Chemistry

Alcohol Abuse and Carbohydrate-Deficient Transferrin Analysis: Are Screening and Confirmatory Analysis Required?(Letters) (Letter to the Editor) Alcohol Abuse and Carbohydrate-Deficient Transferrin Analysis: Are Screening and Confirmatory Analysis Required?(Letters) (Letter to the Editor)
2002
Biological Variation of Vitamins in Blood of Healthy Individuals (Nutrition) Biological Variation of Vitamins in Blood of Healthy Individuals (Nutrition)
2005
Reproducibility of Blood Markers of Oxidative Status and Endothelial Function in Healthy Individuals (Technical Briefs) Reproducibility of Blood Markers of Oxidative Status and Endothelial Function in Healthy Individuals (Technical Briefs)
2003
Homocysteine and Folate Status in an Era of Folic Acid Fortification: Balancing Benefits, Risks, And B-Vitamins (Editorial) Homocysteine and Folate Status in an Era of Folic Acid Fortification: Balancing Benefits, Risks, And B-Vitamins (Editorial)
2008
Genetic Variation in the MTHFR Gene Influences Thiopurine Methyltransferase Activity (Technical Briefs) Genetic Variation in the MTHFR Gene Influences Thiopurine Methyltransferase Activity (Technical Briefs)
2005
D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report) D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report)
2004